Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
23
Frequently Asked Questions
What is Market Cap of Outlook Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Outlook Therapeutics Inc market cap is $46.2M.
What is the 52-week high for Outlook Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Outlook Therapeutics Inc 52 week high is $6.98 as of October 02, 2025.
What is the 52-week low for Outlook Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Outlook Therapeutics Inc 52 week low is $0.79 as of October 02, 2025.
What is Outlook Therapeutics Inc stock price today?
Outlook Therapeutics Inc stock price today is $1.07.
What was Outlook Therapeutics Inc stock price yesterday?
Outlook Therapeutics Inc stock price yesterday was $1.04.
What is the PE ratio of Outlook Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Outlook Therapeutics Inc’s P/E ratio is -0.95.
What is the Price-to-Book ratio of Outlook Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Outlook Therapeutics Inc P/B ratio is -1.2159.
What is the 50-day moving average of Outlook Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Outlook Therapeutics Inc 50-day moving average is $1.62.
How many employess does Outlook Therapeutics Inc has?